These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26918133)

  • 1. Pharmacokinetic-pharmacodynamic relationship of anesthetic drugs: from modeling to clinical use.
    Billard V
    F1000Res; 2015; 4():. PubMed ID: 26918133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling in anesthesia, intensive care and pain medicine.
    Sadean MR; Glass PS
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):463-8. PubMed ID: 19412091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development.
    Kern SE; Stanski DR
    Clin Pharmacol Ther; 2008 Jul; 84(1):153-7. PubMed ID: 18463623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of PK/PD modeling to intravenous anesthesia.
    Minto CF; Schnider TW
    Clin Pharmacol Ther; 2008 Jul; 84(1):27-38. PubMed ID: 18463625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthetics drug pharmacodynamics.
    Bischoff P; Schneider G; Kochs E
    Handb Exp Pharmacol; 2008; (182):379-408. PubMed ID: 18175101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining depth of anesthesia.
    Shafer SL; Stanski DR
    Handb Exp Pharmacol; 2008; (182):409-23. PubMed ID: 18175102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
    Reife RA
    Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early drug distribution: a generally neglected aspect of pharmacokinetics of particular relevance to intravenously administered anesthetic agents.
    Henthorn TK; Krejcie TC; Avram MJ
    Clin Pharmacol Ther; 2008 Jul; 84(1):18-22. PubMed ID: 18563069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia.
    Haas DA; Harper DG
    Anesth Prog; 1992; 39(3):61-8. PubMed ID: 1308374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target controlled anaesthetic drug dosing.
    Schwilden H; Schüttler J
    Handb Exp Pharmacol; 2008; (182):425-50. PubMed ID: 18175103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.
    Martini C; Olofsen E; Yassen A; Aarts L; Dahan A
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):719-28. PubMed ID: 22111858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia.
    Uzun S; Yuce Y; Erden A; Aypar U
    Eur Rev Med Pharmacol Sci; 2014; 18(4):559-65. PubMed ID: 24610623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological models and their use in clinical anaesthesia.
    Schwilden H; Stoeckel H; Schüttler J; Lauven PM
    Eur J Anaesthesiol; 1986 May; 3(3):175-208. PubMed ID: 3536492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models for assessing the relationship between drug concentration and drug effect in performance horses.
    Kamerling SG; Owens JG
    Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response surface models in the field of anesthesia: A crash course.
    Liou JY; Tsou MY; Ting CK
    Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):139-45. PubMed ID: 26321504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and pharmacodynamics in anesthesia, intensive care and pain medicine.
    Heeremans EH; Proost JH; Eleveld DJ; Absalom AR; Struys MM
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):479-84. PubMed ID: 20610985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local anesthetic systemic toxicity: Continuing Professional Development.
    El-Boghdadly K; Chin KJ
    Can J Anaesth; 2016 Mar; 63(3):330-49. PubMed ID: 26830640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.